Verkehr

Bis zum Jahr 2030 hat die direkte Elektrifizierung das größte Treibhausgas-(THG)-Emissionsminderungspotenzial im Verkehrssektor. Da für Pkw und teilweise auch für die Lkw schon jetzt kommerziell wettbewerbsfähige und technisch ausgereifte batterieelektrische Lösungen verfügbar sind, können sich kurzfristige Dekarbonisierungsanstrengungen auf diese Segmente konzentrieren. Selbst mit einem massiven Anstieg des Anteils batterieelektrischer Fahrzeuge werden die Sektorziele aus dem Bundes-Klimaschutzgesetz bis zum Jahr 2030 nicht erreicht und müssen entsprechend von anderen Sektoren kompensiert werden. Die kurzfristigen Minderungspotenziale durch eine reine Antriebswende sind durch die Langlebigkeit der fossilen Bestandsfahr-zeuge begrenzt. Selbst bei einer deutlichen Kostendegression von batterieelektrischen Fahr-zeugen, sehr schnellem Ladeinfrastrukturausbau und hohen CO2-Preisen werden kurzfristig zusätzliche Maßnahmen erforderlich sein, um das Verkehrssektor-Ziel im Jahr 2030 zu erreichen. Hierfür kommen vor allem Maßnahmen zur Änderung des Mobilitätsverhaltens, wie der Wechsel auf andere Verkehrsträger, in Frage. Die indirekte Elektrifizierung (Nutzung der Energieträger Wasserstoff und E-Fuels) bildet bis zum Jahr 2045 in Teilbereichen des Güter-, Personenschienen-und Busverkehrs sowie für den Flugverkehr eine sinnvolle und für Verbrenner-Restbestände bei den Pkweine notwendige Alternative zur direkten Elektrifizierung. Die Nutzung dieser Energieträger erfordert jedoch im Vergleich zur direkten Elektrifizierung einen erheblich größeren Einsatz an Energie, insbesondere erneuerbarem Strom

Triplet Exciton Generation in Bulk-Heterojunction Solar Cells based on Endohedral Fullerenes

Organic bulk-heterojunctions (BHJ) and solar cells containing the trimetallic nitride endohedral fullerene 1-[3-(2-ethyl)hexoxy carbonyl]propyl-1-phenyl-Lu3N@C80 (Lu3N@C80-PCBEH) show an open circuit voltage (VOC) 0.3 V higher than similar devices with [6,6]-phenyl-C[61]-butyric acid methyl ester (PC61BM). To fully exploit the potential of this acceptor molecule with respect to the power conversion efficiency (PCE) of solar cells, the short circuit current (JSC) should be improved to become competitive with the state of the art solar cells. Here, we address factors influencing the JSC in blends containing the high voltage absorber Lu3N@C80-PCBEH in view of both photogeneration but also transport and extraction of charge carriers. We apply optical, charge carrier extraction, morphology, and spin-sensitive techniques. In blends containing Lu3N@C80-PCBEH, we found 2 times weaker photoluminescence quenching, remainders of interchain excitons, and, most remarkably, triplet excitons formed on the polymer chain, which were absent in the reference P3HT:PC61BM blends. We show that electron back transfer to the triplet state along with the lower exciton dissociation yield due to intramolecular charge transfer in Lu3N@C80-PCBEH are responsible for the reduced photocurrent

25th annual computational neuroscience meeting: CNS-2016

The same neuron may play different functional roles in the neural circuits to which it belongs. For example, neurons in the Tritonia pedal ganglia may participate in variable phases of the swim motor rhythms [1]. While such neuronal functional variability is likely to play a major role the delivery of the functionality of neural systems, it is difficult to study it in most nervous systems. We work on the pyloric rhythm network of the crustacean stomatogastric ganglion (STG) [2]. Typically network models of the STG treat neurons of the same functional type as a single model neuron (e.g. PD neurons), assuming the same conductance parameters for these neurons and implying their synchronous firing [3, 4]. However, simultaneous recording of PD neurons shows differences between the timings of spikes of these neurons. This may indicate functional variability of these neurons. Here we modelled separately the two PD neurons of the STG in a multi-neuron model of the pyloric network. Our neuron models comply with known correlations between conductance parameters of ionic currents. Our results reproduce the experimental finding of increasing spike time distance between spikes originating from the two model PD neurons during their synchronised burst phase. The PD neuron with the larger calcium conductance generates its spikes before the other PD neuron. Larger potassium conductance values in the follower neuron imply longer delays between spikes, see Fig. 17.Neuromodulators change the conductance parameters of neurons and maintain the ratios of these parameters [5]. Our results show that such changes may shift the individual contribution of two PD neurons to the PD-phase of the pyloric rhythm altering their functionality within this rhythm. Our work paves the way towards an accessible experimental and computational framework for the analysis of the mechanisms and impact of functional variability of neurons within the neural circuits to which they belong

Spectroscopic Investigation of new Fullerene based Acceptors for Organic Solar Cells

In dieser Arbeit habe ich mich hauptsächlich mit der optischen Spektroskopie im sichtbaren bis nahinfraroten Bereich an Akzeptoren für organische bulk-heterojunction Polymer-Fulleren Solarzellen beschäftigt. Dabei führte ich sowohl Untersuchungen an reinen Fullerenproben als auch Gemischen dieser mit Polymeren durch. Ergänzend sind Messungen zur Morphologie, den Spinzuständen und der Solarzellenleistung erfolgt. Erreicht werden sollte, die generelle Eignung neuartiger Akzeptoren für organische Solarzellen festzustellen, die photoinduzierten spektroskopischen Signaturen von optisch angeregten Anionen auf Fullerenen verschiedener Größe zu finden und zu interpretieren sowie zum Abschluss die Abläufe der Ladungsträgergeneration in Polymer:Lu3N@C80 Solarzellen nachzuvollziehen und dadurch die Ursache der vergleichsweise geringen Stromdichte in diesen Zellen zu verstehen, die 25 % geringer ist als in P3HT:PC60BM Solarzellen. Die Ergebnisse sind, dass C70-C70 Dimer Fullerene sehr gute Akzeptoren darstellen, die neben einer etwas besseren Absorption als C60 basierte Akzeptoren im Bereich um 500 nm sehr gute Fähigkeiten als Elektronenakzeptoren zeigen. Die Messung an Fullerenen verschiedener Größe, um Anionensignaturen zu finden, hat deutliche Signaturen für C60- bei 1.18 eV und für C70- bei 0.92 eV erbracht. Weniger einfach zu finden und interpretieren sind die Signaturen von C80- und C84-. Aufgrund der geringen Signalstärke sowie spezieller Eigenheiten der zur Verfügung stehenden Fullerene konnte ich nur einen ungefähren Bereich von 0.7~eV bis 0.4~eV für die Anionensignaturen abschätzen. Allerdings zeigt sich für alle Fullerene eine Rotverschiebung der Anionensignaturen hin zu niedrigeren Energien mit steigender Zahl der Kohlenstoffatome pro Fulleren. Die umfangreichste Untersuchung habe ich an dem Molekül Lu3N@C80 in seiner Funktion als Elektronenakzeptor in P3HT:Lu3N@C80 Solarzellen gemacht. Während das Molekül in Kombination mit P3HT eine hohe Leerlaufspannung von 835 mV erzeugt, ergeben diese Zellen geringere Stromdichten. Mein Ziel war es, die Prozesse zu identifizieren und zu verstehen, die dafür verantwortlich zeichnen. Aus der Kombination verschiedener Messmethoden, ergänzt mit generellen Erkenntnissen zu endohedralen Fullerenen aus der Literatur, ließ es zu, einen intramolekularen Elektronentransfer von den Lutetiumatomen innerhalb des C80 auf das Fulleren als Ursache zu identifizieren. Die in dieser Arbeit gewonnenen Daten liefern weitere Indizien, dass die Verwendung von C70 basierten Fullerenen eine gute Option zur Verbesserung des Wirkungsgrads von organischen Solarzellen sein kann, trotz der höheren Herstellungskosten. Die gefundenen Anionensignaturen auf den Fullerenen bieten einen weiteren Ansatz, die Anregungsabläufe in verschiedenen bulk-heterojunctions über spektroskopische Messungen nachzuvollziehen. Abschließend habe ich mit meinen Messungen an Lu3N@C80 einen generell zu beachtenden Effekt aufgezeigt, der bei der zukünftigen Synthese funktionaler Akzeptoren ähnlicher Art berücksichtigt werden sollte, um eine optimale Leistungsfähigkeit solcher Moleküle zu gewährleisten. Während die Projekte über die Dimer Akzeptoren und das Lu3N@C80 Molekül abgeschlossen wurden, sind bei der Untersuchung der Anionen, speziell auf großen Fullerenen, noch Fragen offen, und es wären zusätzliche Nachweise wünschenswert. Dies könnte mit spinsensitiven und zeitaufgelösten Messmethoden, die am Lehrstuhl vorhanden sind, an den hier schon vorgestellten Materialien erreicht werden. Eine weitere Möglichkeit wäre es zu versuchen, PC81$BM zu bekommen und dies zu untersuchen, auch in Gemischen mit noch mehr verschiedenen Polymeren mittels photoinduzierter Absorption.The main topic of my thesis was the optical spectroscopy of accepters for organic bulk-heterojunction polymer-fullerene solar cells in the visible till near-infrared regime. Pure fullerene samples as well as blends of fullerenes with polymers were studied. Additionally measurements regarding the morphology, spin states and solar cell performance were done. The aims were to determine the ability of new molecules as acceptors for organic solar cells, to find and understand the photoinduced absorption signatures of optical excited anions on fullerene bulks of different sizes and finally to learn about the charge carrier generation process in polymer:Lu3N@C80 blends and thus understand the origin of the comparable low current density in this devices, about 25 % less than for P3HT:PC60BM solar cells. In our publications due to these topics we presented that the novel C70-C70 dimer fullerenes are fine acceptors for polymer:fullerene solar cells, showing a better absorption coefficient around 500 nm than C60 based acceptors and high singlet-exciton quenching rates. Anion signatures for fullerene molecules of different sizes were clearly found for C60- at 1.18 eV and for C70- at 0.92 eV. Less clear are my findings regarding the signatures for C80- and C84-. Due to the low signal-to-noise ratio in these measurements and some unique properties of the available materials I was only able to indicate a range from 0.7 eV down to 0.4 eV for the optically detected anion signatures of these fullerenes. Still all fullerenes showed a red shift to lower energies for the anion signatures getting stronger the more carbon atoms the fullerenes were made of. The most detailed research in this thesis was done about the Lu3N@C80 molecules application as electron acceptor in P3HT:Lu3N@C80 solar cells. The use of this acceptor in combination with P3HT lead to a high open circuit voltage of 835 mV in the devices produced, but also a rather low current density. I tried to understand the processes in the charge carrier generation and extraction process causing this. Using several measurement techniques, combined with general knowledge about comparable endohedral fullerenes from the literature, I was able to identify an internal charge transfer of electrons from the lutetium atoms encaged in the C80 to the fullerene bulk as origin The results presented in this work give further indications for the advantages of using C70 based fullerene acceptors in organic solar cells to raise the total power conversion efficiencies of these devices, despite the higher production costs. The identification of anion signatures of different fullerenes show an additional method to monitor the excitation processes by optical spectroscopy in bulk-heterojunction devices. My research regarding the Lu3N@C80 molecule showed a general effect regarding this class of molecules, that will be important for any further synthesizes or application of such molecules in organic photovoltaics. While the projects regarding the dimer acceptors and the Lu3N@C80 molecule were completed in this work, the analysis of spectroscopic anion signatures left some open questions, especially for large fullerenes. Further investigations using spin sensitive or time resolved techniques, as available in our research group, could be useful to gather more detailed information on this topic. Also trying to get some PC81BM for photoinduced absorption measurements, alone and in blend with several polymers, might be another way to energetically pinpoint the anion signature on C80

Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1

The lysosomal storage disorders Niemann-Pick disease Type C1 (NPC1) and Type C2 (NPC2) are rare diseases caused by mutations in the NPC1 or NPC2 gene. Both NPC1 and NPC2 are proteins responsible for the exit of cholesterol from late endosomes and lysosomes (LE/LY). Consequently, mutations in one of the two proteins lead to the accumulation of unesterified cholesterol and glycosphingolipids in LE/LY, displaying a disease hallmark. A total of 95% of cases are due to a deficiency of NPC1 and only 5% are caused by NPC2 deficiency. Clinical manifestations include neurological symptoms and systemic symptoms, such as hepatosplenomegaly and pulmonary manifestations, the latter being particularly pronounced in NPC2 patients. NPC1 and NPC2 are rare diseases with the described neurovisceral clinical picture, but studies with human primary patient-derived neurons and hepatocytes are hardly feasible. Obviously, induced pluripotent stem cells (iPSCs) and their derivatives are an excellent alternative for indispensable studies with these affected cell types to study the multisystemic disease NPC1. Here, we present a review focusing on studies that have used iPSCs for disease modeling and drug discovery in NPC1 and draw a comparison to commonly used NPC1 models

Impact of Organelle Transport Deficits on Mitophagy and Autophagy in Niemann–Pick Disease Type C

Defective mitochondria are pathophysiological features of a number of neurodegenerative diseases. Here, we investigated mitochondrial dysfunction in the context of the rare lysosomal storage diseases Niemann–Pick disease type C1 and type C2 (NP-C1 and NP-C2). Mutations in either the NPC1 or NPC2 gene lead to cholesterol accumulation in late endosomes and lysosomes, resulting in impaired cholesterol homeostasis. The extent to which this may lead to mitochondrial dysfunction has been poorly studied so far. Therefore, we investigated the morphology, function, and transport of mitochondria, as well as their degradation via mitophagy, in a disease-associated human neural cell model of NP-C. By performing live cell imaging, we observed markedly reduced mitochondrial transport, although morphology and function were not appreciably altered. However, we observed a defective mitophagy induction shown by a reduced capability to elevate parkin expression and engulf mitochondria in autophagosomes after treatment with carbonyl cyanide 3-chlorophenylhydrazone (CCCP). This was accompanied by defects in autophagy induction, exhibited by a hampered p62 expression and progression, shown by increased LC3BII levels and a defective fusion of autophagosomes and lysosomes. The latter might have been additionally influenced by the observed reduced lysosomal transport. Hence, we hypothesized that a reduced recycling of mitochondria contributes to the pathophysiology of NP-C

Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1

The lysosomal storage disorders Niemann-Pick disease Type C1 (NPC1) and Type C2 (NPC2) are rare diseases caused by mutations in the NPC1 or NPC2 gene. Both NPC1 and NPC2 are proteins responsible for the exit of cholesterol from late endosomes and lysosomes (LE/LY). Consequently, mutations in one of the two proteins lead to the accumulation of unesterified cholesterol and glycosphingolipids in LE/LY, displaying a disease hallmark. A total of 95% of cases are due to a deficiency of NPC1 and only 5% are caused by NPC2 deficiency. Clinical manifestations include neurological symptoms and systemic symptoms, such as hepatosplenomegaly and pulmonary manifestations, the latter being particularly pronounced in NPC2 patients. NPC1 and NPC2 are rare diseases with the described neurovisceral clinical picture, but studies with human primary patient-derived neurons and hepatocytes are hardly feasible. Obviously, induced pluripotent stem cells (iPSCs) and their derivatives are an excellent alternative for indispensable studies with these affected cell types to study the multisystemic disease NPC1. Here, we present a review focusing on studies that have used iPSCs for disease modeling and drug discovery in NPC1 and draw a comparison to commonly used NPC1 models

Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems

Niemann-Pick type C1 (NP-C1) is a fatal, progressive neurodegenerative disease caused by mutations in the NPC1 gene. Mutations of NPC1 can result in a misfolded protein that is subsequently marked for proteasomal degradation. Such loss-of-function mutations lead to cholesterol accumulation in late endosomes and lysosomes. Pharmacological chaperones (PCs) are described to protect misfolded proteins from proteasomal degradation and are being discussed as a treatment strategy for NP-C1. Here, we used a combinatorial approach of high-throughput in silico screening of FDA-approved drugs and in vitro biochemical assays to identify potential PCs. The effects of the hit compounds identified by molecular docking were compared in vitro with 25-hydroxycholesterol (25-HC), which is known to act as a PC for NP-C1. We analyzed cholesterol accumulation, NPC1 protein content, and lysosomal localization in patient-specific fibroblasts, as well as in neural differentiated and hepatocyte-like cells derived from patient-specific induced pluripotent stem cells (iPSCs). One compound, namely abiraterone acetate, showed comparable results to 25-HC and restored NPC1 protein level, corrected the intracellular localization of NPC1, and consequently decreased cholesterol accumulation in NPC1-mutated fibroblasts and iPSC-derived neural differentiated and hepatocyte-like cells. The discovered PC altered not only the pathophysiological phenotype of cells carrying the I1061T mutation— known to be responsive to treatment with PCs—but an effect was also observed in cells carrying other NPC1 missense mutations. Therefore, we hypothesize that the PCs studied here may serve as an effective treatment strategy for a large group of NP-C1 patients

Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the NPC2 Mutations c.58G>T/c.140G>T

Niemann-Pick type C2 (NP-C2) disease is a rare hereditary disease caused by mutations in the NPC2 gene. NPC2 is a small, soluble protein consisting of 151 amino acids, primarily expressed in late endosomes and lysosomes (LE/LY). Together with NPC1, a transmembrane protein found in these organelles, NPC2 accomplishes the exclusion of cholesterol; thus, both proteins are essential to maintain cellular cholesterol homeostasis. Consequently, mutations in the NPC2 or NPC1 gene result in pathophysiological accumulation of cholesterol and sphingolipids in LE/LY. The vast majority of Niemann-Pick type C disease patients, 95%, suffer from a mutation of NPC1, and only 5% display a mutation of NPC2. The biochemical phenotype of NP-C1 and NP-C2 appears to be indistinguishable, and both diseases share several commonalities in the clinical manifestation. Studies of the pathological mechanisms underlying NP-C2 are mostly based on NP-C2 animal models and NP-C2 patient-derived fibroblasts. Recently, we established induced pluripotent stem cells (iPSCs), derived from a donor carrying the NPC2 mutations c.58G>T/c.140G>T. Here, we present a profile of pathophysiological in vitro features, shared by NP-C1 and NP-C2, of neural differentiated cells obtained from the patient specific iPSCs. Profiling comprised a determination of the NPC2 protein level, detection of cholesterol accumulation by filipin staining, analysis of oxidative stress, and determination of autophagy. As expected, the NPC2-deficient cells displayed a significantly reduced amount of NPC2 protein, and, accordingly, we observed a significantly increased amount of cholesterol. Most notably, NPC2-deficient cells displayed only a slight increase of reactive oxygen species (ROS), suggesting that they do not suffer from oxidative stress and express catalase at a high level. As a site note, comparable NPC1-deficient cells suffer from a lack of catalase and display an increased level of ROS. In summary, this cell line provides a valuable tool to gain deeper understanding, not only of the pathogenic mechanism of NP-C2, but also of NP-C1